A Bearz

Summary

Country: Italy

Publications

  1. ncbi request reprint Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case report
    A Bearz
    Department of Medial Oncology B, CRO IRCSS, National Cancer Institute, Aviano, Italy
    Tumori 87:447-50. 2001
  2. ncbi request reprint Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Chemother 21:215-8. 2009
  3. ncbi request reprint Metastatic angiosarcoma of the spleen. A case report and treatment approach
    M Rupolo
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano, Italy
    Tumori 87:439-43. 2001
  4. ncbi request reprint Presurgical chemotherapy (CT) with FOLFOX4-regimen for patients (pts) with unresectable liver metastases (LM) from colorectal cancer (CRC)
    U Tirelli
    National Cancer Institute, Aviano, Italy University General Hospital, Modena, Italy University of Catania, Catania, Italy
    J Clin Oncol 26:15052. 2008
  5. ncbi request reprint FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Chemother 20:503-8. 2008
  6. ncbi request reprint Use of targeted agents in elderly cancer patients (ECP) according to the Comprehensive Geriatric Assessment (CGA)
    L Fratino
    National Cancer Institute, Aviano, Italy
    J Clin Oncol 26:20619. 2008
  7. ncbi request reprint MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients
    A Bearz
    Division of Medical Oncology A, National Cancer Institute, Aviano, Pordenone, Italy
    Int J Biol Markers 22:307-11. 2007
  8. ncbi request reprint Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature
    M Berretta
    Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:221-4. 2006
  9. ncbi request reprint The impact of HCV co-infection on the outcome and the clinical features of HIV-related non-Hodgkin lymphoma (NHL)
    C Simonelli
    National Cancer Institute, Aviano, Italy
    J Clin Oncol 26:19504. 2008
  10. ncbi request reprint Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:1S-19S. 2012

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Occult small cell lung cancer associated with paraneoplastic neurologic syndrome: case report
    A Bearz
    Department of Medial Oncology B, CRO IRCSS, National Cancer Institute, Aviano, Italy
    Tumori 87:447-50. 2001
    ..The course of the small cell lung cancer was very indolent and the paraneoplastic neurologic syndrome did not worsen with the use of cisplatin...
  2. ncbi request reprint Leiomyosarcoma of the parotid gland in an HIV-positive patient: therapeutic approach, clinical course and review of the literature
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Chemother 21:215-8. 2009
    ..The ability to use combined modality interventions in patients with secondary malignancies and immunosuppression requires further study with focus on both tolerance and efficacy...
  3. ncbi request reprint Metastatic angiosarcoma of the spleen. A case report and treatment approach
    M Rupolo
    Divisione di Oncologia Medica, Centro di Riferimento Oncologico, IRCCS, Istituto Nazionale Tumori, Aviano, Italy
    Tumori 87:439-43. 2001
    ....
  4. ncbi request reprint Presurgical chemotherapy (CT) with FOLFOX4-regimen for patients (pts) with unresectable liver metastases (LM) from colorectal cancer (CRC)
    U Tirelli
    National Cancer Institute, Aviano, Italy University General Hospital, Modena, Italy University of Catania, Catania, Italy
    J Clin Oncol 26:15052. 2008
    ..Primary objective of this study was to evaluate resecability rate of LM in pts with un-resectable disease, after "neoadjuvant" CT with FOLFOX4-regimen and secondary objective is to evaluate the objective response and CT toxicity...
  5. ncbi request reprint FOLFOX2 in the treatment of advanced colorectal cancer: a comparison between elderly and middle aged patients
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Chemother 20:503-8. 2008
    ..9 and 21.8 months, respectively) between middle aged and elderly patients. The FOLFOX2 regimen provides equivalent feasibility, efficacy, and survival gain in middle-aged and in elderly patients with metastatic CRC...
  6. ncbi request reprint Use of targeted agents in elderly cancer patients (ECP) according to the Comprehensive Geriatric Assessment (CGA)
    L Fratino
    National Cancer Institute, Aviano, Italy
    J Clin Oncol 26:20619. 2008
    ..In this study, we describe the results obtained using oral targeted therapies in ECP assessed through the CGA...
  7. ncbi request reprint MUC-1 (CA 15-3 antigen) as a highly reliable predictor of response to EGFR inhibitors in patients with bronchioloalveolar carcinoma: an experience on 26 patients
    A Bearz
    Division of Medical Oncology A, National Cancer Institute, Aviano, Pordenone, Italy
    Int J Biol Markers 22:307-11. 2007
    ..No tumor marker has been validated in the diagnosis and follow-up of lung cancer, in particular to predict the outcome of treatment with EGFR inhibitors...
  8. ncbi request reprint Metastatic angiosarcoma of the kidney: a case report with treatment approach and review of the literature
    M Berretta
    Dipartimento di Oncologia Medica, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:221-4. 2006
    ..Antiangiogenetic agents are of interest for this disease due to the peculiar origin of the cells of these sarcomas...
  9. ncbi request reprint The impact of HCV co-infection on the outcome and the clinical features of HIV-related non-Hodgkin lymphoma (NHL)
    C Simonelli
    National Cancer Institute, Aviano, Italy
    J Clin Oncol 26:19504. 2008
    ..19504 Background: Epidemiological studies show an association between HCV and B NHL. Treatment and outcome of patients with NHL and HCV infection in the general population and in HIV-infected population are still debated...
  10. ncbi request reprint Antiblastic treatment, for solid tumors, during pregnancy: a crucial decision
    M Berretta
    Department of Medical Oncology, National Cancer Institute, Aviano PN, Italy
    Int J Immunopathol Pharmacol 25:1S-19S. 2012
    ..This article reviews the available data regarding the different aspects of the treatment of cancer during pregnancy...
  11. ncbi request reprint Pemetrexed in second-line treatment in advanced NSCLC: An experience on 131 patients
    A Bearz
    National Cancer Institute, Aviano, Italy IRCCS Humanitas, Milano, Italy Veneto Oncologic Institute, Padova, Italy General Hospital, Pordenone, Italy
    J Clin Oncol 26:19114. 2008
    ..Herein we analyzed the data about patients in second-line therapy only, 128, which we added data from 3 more patients...
  12. ncbi request reprint Cetuximab/targeted chemotherapy in an HIV-positive patient with metastatic colorectal cancer in the HAART era: a case report
    M Berretta
    Division of Medical Oncology A, National Cancer Institute, Aviano, Italy
    J Chemother 19:343-6. 2007
    ..This case suggests that, in the HAART era, a multidisciplinary approach can be offered to HIV patients with advanced cancer when they have good performance status, resulting in efficacious control of the HIV infection...
  13. pmc Target therapies in lung cancer
    A Bearz
    Department of Medical Oncology, National Cancer Institute, CRO IRCCS, Aviano, Italy
    J Biomed Biotechnol 2011:921231. 2011
    ..The increased specificity should lead to decreased toxicity and better activity. Herein we provide an update of the main target therapies in development or already available for the treatment of nonsmall cell lung cancer...
  14. ncbi request reprint Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological study
    R Sorio
    Medical Department, Centro di Riferimento Oncologico, Aviano, Italy
    J Chemother 18:188-91. 2006
    ..The easy self-management, favorable toxicity profile and synergy with other compounds makes oral etoposide suitable for further clinical-pharmacological studies in elderly patients...
  15. ncbi request reprint Dysphonia as an unusual toxic event of oxaliplatin-based chemotherapy
    M Berretta
    Division of Medical Oncology A and 3B National Cancer Institute, Aviano, Italy
    J Chemother 16:595-8. 2004
    ..This toxic effect was self-limiting and all patients recovered rapidly. Nonetheless, a deeper understanding of this phenomenon is essential to give correct information to the patients...